A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NCT05759793
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsed/Refractory Multiple Myeloma
Plasma Cell Leukemia
Interventions
DRUG:
CAR-GPRC5D
Sponsor
Nanjing IASO Biotechnology Co., Ltd.
Collaborators
[object Object]